Clinical Trial

Clareon Toric Study (T2-T9)

Completed
View on ClinicalTrials.gov →
Summary
The purpose of this post-market study is to describe the long-term safety and performance of Clareon Toric Intraocular Lenses (IOLs).
Protocol Amendment History 3 changes
critical Trial completed 2026-07-29
notable Primary completion moved earlier: 2028-07 -> 2026-06-25 2026-07-29
minor Completion moved earlier: 2028-07 -> 2026-06-25 2026-07-29
Trial Details
NCT Number NCT06285695
Lead Sponsor Alcon Research
Conditions Aphakia, Corneal Astigmatism
Enrollment 129 participants
Start Date 2024-04-10
Primary Completion 2026-06-25 (estimated)
Study Completion 2026-06-25 (estimated)
Updated on ClinicalTrials.gov 2026-07-28